With major expansion projects already underway at several of its Madison-area sites, Exact Sciences Corp. is also in line for a new corporate headquarters at University Research Park that could add 200 to 440 new jobs there over the coming years. Aaron Olver, director of University...
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has completed enrollment of a Phase 1 clinical study of ARO-AAT, the company’s second generation subcutaneously administered RNA interference (RNAi) therapeutic being developed. READ FULL STORY...
JangoBio is seeing positive results from ongoing animal testing for a therapy that could be used to treat aging-related diseases. The therapy in question relies on stem cells to regrow key tissues that play a key role in balancing hormones. These tissues naturally degrade as the...
A Madison stem cell company plans to manufacture specialized brain cells that it says could help researchers create a path toward better drugs to treat Alzheimer’s and other neurological diseases. Fujifilm Cellular Dynamics Inc. has signed an agreement with the University of California-Irvine for an exclusive...
Exact Sciences Corp. and the Mayo Clinic say they’ve developed a blood test that correctly identified 95 percent of the cases of a common form of liver cancer. The news, released Tuesday in a presentation at a major conference of gastroenterologists, is a signal that the...
Before co-working spaces there were coffee shops. Popular among college students, freelancers and other members of the gig economy escaping the isolation and distraction of working from home, these “third spaces” were — and still are — great places to throw on your headphones and get some work done....
Exact Sciences stock jumped as much as 13 percent on Wednesday after the American Cancer Society said people should be screened for colorectal cancer at age 45, lowering its guidelines from the current recommended age of 50. Exact, of Madison, makes Cologuard, a stool test for...
A Madison company that's working on a universal influenza vaccine has started a clinical trial using its vaccine to protect against a flu strain that doesn't match up. FluGen says the first subject has received a dose of its M2SR vaccine, also known as RedeeFlu, in...
Protecting production crops against bacterial invasion is an eternal struggle for agriculture. Antibiotics can’t address everything that poses a threat, and many pathogens have evolved to become resistant to antibiotics. Novel ways to address bacterial pathogens must be developed to keep crops safe and available for...
Invenra, a URP tenant / biotech startup that develops therapeutic antibodies for pharma companies, is joining forces with a Bay Area company to discover and develop new treatments for cancer. Under the agreement, Exelixis will pay Invenra $2 million upfront, plus an additional $2 million at...